Cargando…
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells
Among others, expression levels of programmed cell death 1 ligand 1 (PD‐L1) have been explored as biomarkers of the response to immune checkpoint inhibitors in cancer therapy. Here, we present the results of a chemical screen that interrogated how medically approved drugs influence PD‐L1 expression....
Autores principales: | Hühn, Daniela, Martí‐Rodrigo, Pablo, Mouron, Silvana, Hansel, Catherine, Tschapalda, Kirsten, Porebski, Bartlomiej, Häggblad, Maria, Lidemalm, Louise, Quintela‐Fandino, Miguel, Carreras‐Puigvert, Jordi, Fernandez‐Capetillo, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732350/ https://www.ncbi.nlm.nih.gov/pubmed/34392603 http://dx.doi.org/10.1002/1878-0261.13083 |
Ejemplares similares
-
New regulators of the tetracycline‐inducible gene expression system identified by chemical and genetic screens
por: Colicchia, Valeria, et al.
Publicado: (2022) -
Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach
por: Bueno, Maria J, et al.
Publicado: (2017) -
Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
por: Mouron, Silvana, et al.
Publicado: (2021) -
A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors
por: Corman, Alba, et al.
Publicado: (2021) -
A chemical screen underscores the essential role of STAT1-dependent IFNγ signaling to regulate HLA-I expression in cancer cells
por: Barz, Myriam, et al.
Publicado: (2023)